258 related articles for article (PubMed ID: 30348701)
1. Impact of FDG-PET on the Detection of Patients with Lung Cancer at High Risk for ILD.
Flechsig P; Hural O; Kreuter M; Eichhorn M; HEUßEL G; Sachpekidis C; Kauczor HU; Haberkorn U; Heussel CP; Eichinger M
In Vivo; 2018; 32(6):1457-1462. PubMed ID: 30348701
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of
Akaike K; Saruwatari K; Oda S; Shiraishi S; Takahashi H; Hamada S; Iyama S; Horio Y; Tomita Y; Saeki S; Okamoto S; Ichiyasu H; Fujii K; Sakagami T
Int J Clin Oncol; 2020 Apr; 25(4):681-690. PubMed ID: 31781994
[TBL] [Abstract][Full Text] [Related]
3. Can FDG-PET/CT imaging be used to predict decline in quality of life in interstitial lung disease? A prospective study of the relationship between FDG uptake and quality of life in a UK outpatient setting.
Jordon LH; Ganeshan B; Nadeem I; Hoy L; Mahdi N; Porter JC; Groves A; Win T
BMJ Open; 2024 May; 14(5):e081103. PubMed ID: 38816048
[TBL] [Abstract][Full Text] [Related]
4. 18F-FDG Uptake in Less Affected Lung Field Provides Prognostic Stratification in Patients with Interstitial Lung Disease.
Nobashi T; Kubo T; Nakamoto Y; Handa T; Koyasu S; Ishimori T; Mishima M; Togashi K
J Nucl Med; 2016 Dec; 57(12):1899-1904. PubMed ID: 27339874
[TBL] [Abstract][Full Text] [Related]
5. Is
Lee SH; Sung C; Lee HS; Yoon HY; Kim SJ; Oh JS; Song JW; Kim MY; Ryu JS
Ann Nucl Med; 2018 Aug; 32(7):492-498. PubMed ID: 29974372
[TBL] [Abstract][Full Text] [Related]
6. Multiple values of
Li Y; Zhou Y; Wang Q
Clin Rheumatol; 2017 Oct; 36(10):2297-2305. PubMed ID: 28831580
[TBL] [Abstract][Full Text] [Related]
7. The quantitative assessment of interstitial lung disease with positron emission tomography scanning in systemic sclerosis patients.
Peelen DM; Zwezerijnen BGJC; Nossent EJ; Meijboom LJ; Hoekstra OS; Van der Laken CJ; Voskuyl AE
Rheumatology (Oxford); 2020 Jun; 59(6):1407-1415. PubMed ID: 31642912
[TBL] [Abstract][Full Text] [Related]
8. (18)FDG uptake associated with CT density on PET/CT in lungs with and without chronic interstitial lung diseases.
Inoue K; Okada K; Taki Y; Goto R; Kinomura S; Fukuda H
Ann Nucl Med; 2009 May; 23(3):277-81. PubMed ID: 19319629
[TBL] [Abstract][Full Text] [Related]
9. Clinical value of
Motegi SI; Fujiwara C; Sekiguchi A; Hara K; Yamaguchi K; Maeno T; Higuchi T; Hirasawa H; Kodaira S; Tomonaga H; Tsushima Y; Ishikawa O
J Dermatol; 2019 Mar; 46(3):213-218. PubMed ID: 30614031
[No Abstract] [Full Text] [Related]
10. Acute exacerbation of interstitial lung disease with lung cancer after surgery: evaluation with 2-[18]-fluoro-2-deoxy-D-glucose positron emission tomography.
Maniwa T; Endo M; Isaka M; Nakagawa K; Ohde Y; Okumura T; Kondo H
Surg Today; 2014 Mar; 44(3):494-8. PubMed ID: 24006127
[TBL] [Abstract][Full Text] [Related]
11. Association between F-18 fluorodeoxyglucose uptake of noncancerous lung area and acute exacerbation of interstitial pneumonia in patients with lung cancer after resection.
Yamamichi T; Shimada Y; Masuno R; Ohira T; Abe S; Yoshimura A; Ikeda N
J Thorac Cardiovasc Surg; 2020 Mar; 159(3):1111-1118.e2. PubMed ID: 31587890
[TBL] [Abstract][Full Text] [Related]
12. Absence of early metabolic response assessed by 18F-FDG PET/CT after initiation of antifibrotic drugs in IPF patients.
Bondue B; Castiaux A; Van Simaeys G; Mathey C; Sherer F; Egrise D; Lacroix S; Huaux F; Doumont G; Goldman S
Respir Res; 2019 Jan; 20(1):10. PubMed ID: 30646908
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and Treatment of Lung Cancer in the Setting of Interstitial Lung Disease.
Fisher DA; Murphy MC; Montesi SB; Hariri LP; Hallowell RW; Keane FK; Lanuti M; Mooradian MJ; Fintelmann FJ
Radiol Clin North Am; 2022 Nov; 60(6):993-1002. PubMed ID: 36202484
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary
Win T; Screaton NJ; Porter JC; Ganeshan B; Maher TM; Fraioli F; Endozo R; Shortman RI; Hurrell L; Holman BF; Thielemans K; Rashidnasab A; Hutton BF; Lukey PT; Flynn A; Ell PJ; Groves AM
Eur J Nucl Med Mol Imaging; 2018 May; 45(5):806-815. PubMed ID: 29335764
[TBL] [Abstract][Full Text] [Related]
15.
Ledoult E; Morelle M; Soussan M; Mékinian A; Béhal H; Sobanski V; Hachulla E; Huglo D; Le Gouellec N; Remy-Jardin M; Baillet C; Launay D
Arthritis Res Ther; 2021 Mar; 23(1):76. PubMed ID: 33673861
[TBL] [Abstract][Full Text] [Related]
16. Increased
Fukunaga K; Nagatani Y; Nakagawa H; Nitta-Seko A; Nagata T; Nishizono M; Kobashi K; Iguchi H; Nitta N; Hanaoka J; Murata K; Watanabe Y; Nakano Y
Eur J Radiol; 2021 Feb; 135():109477. PubMed ID: 33401111
[TBL] [Abstract][Full Text] [Related]
17. Clinical profile of unclassifiable interstitial lung disease: Comparison with chronic fibrosing idiopathic interstitial pneumonias.
Traila D; Oancea C; Tudorache E; Mladinescu OF; Timar B; Tudorache V
J Int Med Res; 2018 Jan; 46(1):448-456. PubMed ID: 28758849
[TBL] [Abstract][Full Text] [Related]
18. Predictors of idiopathic pulmonary fibrosis in absence of radiologic honeycombing: A cross sectional analysis in ILD patients undergoing lung tissue sampling.
Salisbury ML; Xia M; Murray S; Bartholmai BJ; Kazerooni EA; Meldrum CA; Martinez FJ; Flaherty KR
Respir Med; 2016 Sep; 118():88-95. PubMed ID: 27578476
[TBL] [Abstract][Full Text] [Related]
19. Novel positron emission tomography/computed tomography of diffuse parenchymal lung disease combining a labeled somatostatin receptor analogue and 2-deoxy-2[18F]fluoro-D-glucose.
Win T; Screaton NJ; Porter J; Endozo R; Wild D; Kayani I; Dickson J; Shortman RI; Reubi JC; Ell PJ; Groves AM
Mol Imaging; 2012 Apr; 11(2):91-8. PubMed ID: 22469237
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDG PET/CT and HRCT: a combined tool for risk stratification in idiopathic inflammatory myopathy-associated interstitial lung disease.
Zhang Y; Chen Z; Long Y; Zhang B; He Q; Tang K; Zhang X
Clin Rheumatol; 2022 Oct; 41(10):3095-3105. PubMed ID: 35759126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
